A randomized, double-blinded, sham-controlled trial of postpartum extracorporeal magnetic innervation to restore pelvic muscle strength in primiparous patients.
OBJECTIVE
The purpose of this study was to determine the effects of extracorporeal magnetic innervation (ExMI) on pelvic muscle strength of primiparous patients.


METHODS
Primigravid patients were randomized to receive either active or sham ExMI postpartum treatments for 8 weeks. The main outcome measure was pelvic muscle strength measured by perineometry at baseline (midtrimester), 6 weeks (before treatments), 14 weeks, 6 months, and 12 months postpartum. Mixed randomized-repeated measures ANOVA was used to analyze the mean perineometry values between the 2 groups and across all 5 time periods.


RESULTS
Fifty-one patients enrolled, and 18 were lost to attrition. There were no differences in demographics or delivery characteristics between the active and sham groups. There was an overall time effect, F(3,85) = 3.1, P = .049, but no group, F(1,31) = 0.007, P = .94, or (group)(time) interaction, F(3,85) = 1.8, P = .15.


CONCLUSIONS
We found no differences in pelvic muscle strength between patients receiving active or sham ExMI treatments in the early postpartum period.
Culligan
Patrick J
PJ
Department of Obstetrics, Gynecology and Women's Health-Division of Urogynecology and Reconstructive Pelvic Surgery, University of Louisville Health Sciences Center, KY 40202, USA. patrick.culligan@ahsys.org
Blackwell
Linda
L
Murphy
Miles
M
Ziegler
Craig
C
Heit
Michael H
MH
D000328:Adult; D004311:Double-Blind Method; D004599:Electric Stimulation Therapy; D005260:Female; D006801:Humans; D008280:Magnetics; D009135:Muscular Diseases / Q000503:physiopathology / Q000628:therapy*; D010298:Parity; D017773:Pelvic Floor / Q000503:physiopathology*; D011644:Puerperal Disorders / Q000503:physiopathology / Q000628:therapy*; D017211:Treatment Failure